Hypochlorous acid-modified low-density lipoprotein inactivates the lysosomal protease cathepsin B: protection by ascorbic and lipoic acids

Author： Carr A.C.  

Publisher： Maney Publishing

ISSN： 1743-2928

Source： Redox Report, Vol.6, Iss.6, 2001-12, pp. : 343-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity

By  

Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. : 932-936

Bentham Science Publishers

Access to resources Recommend Favorite

Intensive Reduction of Low-Density Lipoprotein-Cholesterol: Implications of Recent Trials

By Hackam Daniel G.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 367-371

Adis International

Access to resources Recommend Favorite

Effects on Coronary Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol with Statins

By Ferrières Jean  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 2, 2009-01 ,pp. : 109-115

Adis International

Access to resources Recommend Favorite

Effects of Paroxetine and Sertraline on Low-Density Lipoprotein Cholesterol: An Observational Cohort Study

By Wei Feifei   Crain A. Lauren   Whitebird Robin R.   Godlevsky Olga V.   O'Connor Patrick J.  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 857-865

Adis International

Access to resources Recommend Favorite

-Lipoic acid and -lipoamide prevent oxidant-induced lysosomal rupture and apoptosis

By Persson H.L.   Svensson A.I.   Brunk U.T.  

Redox Report, Vol. 6, Iss. 5, 2001-10 ,pp. : 327-334

Maney Publishing

Access to resources Recommend Favorite